Symptoms, complications and management of long COVID: a review
OL Aiyegbusi, SE Hughes, G Turner… - Journal of the Royal …, 2021 - journals.sagepub.com
Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3
million deaths. While the majority of infected individuals recover, a significant proportion …
million deaths. While the majority of infected individuals recover, a significant proportion …
COVID-19 and the liver
D Jothimani, R Venugopal, MF Abedin… - Journal of …, 2020 - Elsevier
The current coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), has become a major public health crisis …
respiratory syndrome coronavirus-2 (SARS-CoV-2), has become a major public health crisis …
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study
Objective To assess medium-term organ impairment in symptomatic individuals following
recovery from acute SARS-CoV-2 infection. Design Baseline findings from a prospective …
recovery from acute SARS-CoV-2 infection. Design Baseline findings from a prospective …
[HTML][HTML] Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19
We present an integrated analysis of the clinical measurements, immune cells, and plasma
multi-omics of 139 COVID-19 patients representing all levels of disease severity, from serial …
multi-omics of 139 COVID-19 patients representing all levels of disease severity, from serial …
Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study
Objective To quantify rates of organ specific dysfunction in individuals with covid-19 after
discharge from hospital compared with a matched control group from the general …
discharge from hospital compared with a matched control group from the general …
[HTML][HTML] ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19
M Dong, J Zhang, X Ma, J Tan, L Chen, S Liu… - Biomedicine & …, 2020 - Elsevier
At the end of 2019, the coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Currently, it is …
respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Currently, it is …
[HTML][HTML] Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective …
Background COVID-19 is a multisystem disease and patients who survive might have in-
hospital complications. These complications are likely to have important short-term and long …
hospital complications. These complications are likely to have important short-term and long …
The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in countless
infections and caused millions of deaths since its emergence in 2019. Coronavirus disease …
infections and caused millions of deaths since its emergence in 2019. Coronavirus disease …
COVID-19 and gastrointestinal disease: implications for the gastroenterologist
Background: COVID-19 was initially considered a respiratory disease but the SARS-CoV-2
virus can lead to serious systemic consequences affecting major organs including the …
virus can lead to serious systemic consequences affecting major organs including the …
Multi-organ impairment in low-risk individuals with long COVID
Background Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection has
disproportionately affected older individuals and those with underlying medical conditions …
disproportionately affected older individuals and those with underlying medical conditions …